Scotiabank Initiates Coverage On Exact Sciences with Sector Outperform Rating, Announces Price Target of $70
Portfolio Pulse from Benzinga Newsdesk
Scotiabank has initiated coverage on Exact Sciences (NASDAQ:EXAS) with a Sector Outperform rating and a price target of $70.
June 27, 2024 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Scotiabank has initiated coverage on Exact Sciences with a Sector Outperform rating and a price target of $70, indicating a positive outlook for the stock.
The initiation of coverage with a Sector Outperform rating and a price target of $70 by Scotiabank is likely to boost investor confidence in Exact Sciences. This positive analyst rating can lead to increased buying interest and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100